Elanco updates Q3 2024 earnings guidance with lower EPS and revenue than consensus estimates.

Elanco Animal Health (NYSE: ELAN) updated its Q3 2024 earnings guidance, predicting an EPS of 0.090-0.140 and revenue of $1.0-$1.1B, lower than consensus estimates. Elanco's FY 2024 guidance was updated to 0.880-0.960 EPS. The company, which offers pet and farm animal health products, saw its stock price increase to $13.04 on Friday with a trading volume of 4.9M shares. Elanco's consensus rating is Moderate Buy, with a target price of $17.57.